Rodman David Malcom
SEC insider (Form 3/4/5 filer). CIK 0001672659. Chief Medical Officer at Mineralys Therapeutics, Inc. (MLYS). 118 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in RADNOR, PA.
Companies Rodman David Malcom has filed insider reports for
- Mineralys Therapeutics, Inc. (MLYS): Officer, Chief Medical Officer
Rodman David Malcom
CIK: 0001672659
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Mineralys Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (118 total)
- Aug 10, 2026MLYS
Mineralys Therapeutics, Inc.
SaleDirect2.2K shares at avg. $27.09$59K - Aug 10, 2026MLYS
Mineralys Therapeutics, Inc.
ExerciseDirect2.2K shares at avg. $16.00$35K - Jul 17, 2026MLYS
Mineralys Therapeutics, Inc.
SaleDirect416 shares at avg. $26.53$11K - Jul 17, 2026MLYS
Mineralys Therapeutics, Inc.
ExerciseDirect416 shares at avg. $15.44$6K - Jul 15, 2026MLYS
Mineralys Therapeutics, Inc.
SaleDirect6.3K shares at avg. $26.61$169K - Jul 13, 2026MLYS
Mineralys Therapeutics, Inc.
ExerciseDirect6.3K shares at avg. $1.08$7K - Jul 13, 2026MLYS
Mineralys Therapeutics, Inc.
SaleDirect14.1K shares at avg. $27.58$388K - Jul 13, 2026MLYS
Mineralys Therapeutics, Inc.
ExerciseDirect3.5K shares at avg. $10.20$36K - Jul 13, 2026MLYS
Mineralys Therapeutics, Inc.
ExerciseDirect4.2K shares at avg. $14.25$59K - Jul 9, 2026MLYS
Mineralys Therapeutics, Inc.
SaleDirect2.2K shares at avg. $30.30$66K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 | MLYS Mineralys Therapeutics, Inc. | Sale | 2,170 | $27.09 | $58,785 | Direct |
| Aug 10, 2026 | MLYS Mineralys Therapeutics, Inc. | Exercise | 2,170 | $16.00 | $34,720 | Direct |
| Jul 17, 2026 | MLYS Mineralys Therapeutics, Inc. | Sale | 416 | $26.53 | $11,036 | Direct |
| Jul 17, 2026 | MLYS Mineralys Therapeutics, Inc. | Exercise | 416 | $15.44 | $6,423 | Direct |
| Jul 15, 2026 | MLYS Mineralys Therapeutics, Inc. | Sale | 6,349 | $26.61 | $168,955 | Direct |
| Jul 13, 2026 | MLYS Mineralys Therapeutics, Inc. | Exercise | 6,349 | $1.08 | $6,857 | Direct |
| Jul 13, 2026 | MLYS Mineralys Therapeutics, Inc. | Sale | 14,058 | $27.58 | $387,717 | Direct |
| Jul 13, 2026 | MLYS Mineralys Therapeutics, Inc. | Exercise | 3,542 | $10.20 | $36,128 | Direct |
| Jul 13, 2026 | MLYS Mineralys Therapeutics, Inc. | Exercise | 4,167 | $14.25 | $59,380 | Direct |
| Jul 9, 2026 | MLYS Mineralys Therapeutics, Inc. | Sale | 2,171 | $30.30 | $65,781 | Direct |
1-10 of 118 transactions